Serious liver disease induced by infliximab

Infliximab, a chimeric monoclonal antibody that binds the tumor necrosis factor ? (TNF?), is used in the treatment of rheumatoid arthritis (RA) and Crohn’s disease (CD). Previous cases of significant secondary liver disease associated with infliximab treatment have been reported in patients with RA,...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2006

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/25955

Acceso en línea:

https://doi.org/10.1007/s10067-005-0169-y
https://repository.urosario.edu.co/handle/10336/25955

Palabra clave:

monoclonal antibody
tumor necrosis factor
Crohn’s disease
psoriatic arthritis

Rights

License

Restringido (Acceso a grupos específicos)